MASON, Ohio–(BUSINESS WIRE)–AtriCure Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that it has been named a winner of the 2022 Diversity, Equity & Inclusion Award from the National Association of Corporate Directors (NACD) as the top company in the Small Cap – Public Company category. The award recognizes boards that have improved their
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.